Forschungsprojekte
Ergebnisse pro Seite:
50
2022 - 2025
Type-I Interferons – a double-edged sword in myeloproliferative neoplasms and chronic viral infections (SFB 1292, TP21)- Prof. Dr. MarkusRadsak,
- Dr. SabineMuth
2022 - 2026
Exploring KrasG12V-specific TCR-like CAR redirected T cells for immunotherapy in non-small cell lung cancer (NSCLC)- PD Dr. UdoHartwig
2022 - 2023
Large optic discs in children versus large optic discs in adults: Is there a difference?- Univ.-Prof. Dr. Esther M.Hoffmann
2022 - 2023
Preclinical evaluation of an anti-lL-36R antibody treatment as a new therapy approach for IL-17A-NFKBIZ-driven psoriasis- Univ.-Prof. Dr. StephanGrabbe,
- Dr. DanielaKramer
2022 - 2025
“Analysis of extracellular vesicles to overcome cisplatin resistances in solid tumors” (LiquidResistantVesicles)- Dr. JanHagemann,
- Dr. DésiréeGül,
- Prof. Dr. RolandStauber
2022
Machbarkeitsstudie - Ist eine Therapie mit dem VITA-System mit frühen Schlaganfallpatienten möglich?- Dr. JürgenKonradi,
- Dr. UlrichBetz
2022 - 2026
Verbund PEARL - Prävention von Darmkrebs im jungen und mittleren Erwachsenenalter- Univ.-Prof. Dr. WilfriedRoth
2021 - 2025
Tumorspezifische Immunisierung durch transkutane Impfung: Präklinische und klinische Entwicklung von Arzneiformen zur adjuvanten Therapie des Mantelzell-Karzinoms (SFB 1066/3, TP B18)- Prof. Dr. MarkusRadsak,
- Prof. Dr. PeterLangguth,
- Univ.-Prof. Dr. StephanGrabbe
2021 - 2040
Therapie der Myelofibrose mit KRT-232 in Kombination mit Ruxolitinib (#1262)- Prof. Dr. MarkusRadsak
2021 - 2022
Novel natural substances from the Baka ethnobotanical empirical knowledge for the management of urological cancers- PD Dr. Dr. EvaJüngel
2021 - 2022
The impact of shikonin combination therapy on the development of therapy resistance in advanced renal cell carcinoma- PD Dr. Dr. EvaJüngel
2021 - 2022
ABCDEF-COOP: The role of chronic illness on psychosocial strain of school children and their families during the Covid-19 pandemic- Dr. SophieLukes,
- FlorianHammerle
2021 - 2022
Growth behavior of bladder cancer after combined application with cisplatin and artesunat- PD Dr. Dr. EvaJüngel
2021 - 2023
Stellenwert der HDAC-Inhibition für die Therapie des fortgeschrittenen Peniskarzinoms- IgorTsaur
2021 - 2024
Impact of cholesterol- and lipid-homeostasis in patients with advanced and pre-treated prostate cancer (Palltur)- MaximilianBrandt
2021 - 2024
Targeting chromatin complexes to reverse AML immune escape for engineered cell therapy (SFB 1292, TP 12)- Dr. MichaelKühn,
- Prof. Dr. EvelynUllrich
2021 - 2023
Utilization of the HLA-independent anti-tumor T-cell repertoire for cancer immunotherapy- Univ.-Prof. Dr. ThomasWölfel